Miltrate en es it fr

Miltrate Brand names, Miltrate Analogs

Miltrate Brand Names Mixture

  • No information avaliable

Miltrate Chemical_Formula


Miltrate RX_link

No information avaliable

Miltrate fda sheet

Miltrate msds (material safety sheet)

Miltrate Synthesis Reference

No information avaliable

Miltrate Molecular Weight

309.469 g/mol

Miltrate Melting Point

< 25 oC

Miltrate H2O Solubility

Soluble as HCl salt

Miltrate State


Miltrate LogP


Miltrate Dosage Forms

Tablets (oral, 1 mg)

Miltrate Indication

Used for the symptomatic treatment of parkinsonism.

Miltrate Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Miltrate Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Miltrate side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Miltrate Patient Information

Miltrate Organisms Affected

Humans and other mammals